BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Christensen A, Juhl K, Persson M, Charabi BW, Mortensen J, Kiss K, Lelkaitis G, Rubek N, von Buchwald C, Kjær A. uPAR-targeted optical near-infrared (NIR) fluorescence imaging and PET for image-guided surgery in head and neck cancer: proof-of-concept in orthotopic xenograft model. Oncotarget 2017;8:15407-19. [PMID: 28039488 DOI: 10.18632/oncotarget.14282] [Cited by in Crossref: 29] [Cited by in F6Publishing: 33] [Article Influence: 5.8] [Reference Citation Analysis]
Number Citing Articles
1 Kurbegovic S, Juhl K, Chen H, Qu C, Ding B, Leth JM, Drzewiecki KT, Kjaer A, Cheng Z. Molecular Targeted NIR-II Probe for Image-Guided Brain Tumor Surgery. Bioconjug Chem 2018;29:3833-40. [PMID: 30296054 DOI: 10.1021/acs.bioconjchem.8b00669] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 6.5] [Reference Citation Analysis]
2 Wu J, Yuan Y, Tao XF. Targeted molecular imaging of head and neck squamous cell carcinoma: a window into precision medicine. Chin Med J (Engl) 2020;133:1325-36. [PMID: 32404691 DOI: 10.1097/CM9.0000000000000751] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
3 Qualliotine JR, Bolat G, Beltrán-Gastélum M, de Ávila BE, Wang J, Califano JA. Acoustic Nanomotors for Detection of Human Papillomavirus-Associated Head and Neck Cancer. Otolaryngol Head Neck Surg 2019;161:814-22. [PMID: 31547769 DOI: 10.1177/0194599819866407] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
4 Debie P, Vanhoeij M, Poortmans N, Puttemans J, Gillis K, Devoogdt N, Lahoutte T, Hernot S. Improved Debulking of Peritoneal Tumor Implants by Near-Infrared Fluorescent Nanobody Image Guidance in an Experimental Mouse Model. Mol Imaging Biol 2018;20:361-7. [PMID: 29090412 DOI: 10.1007/s11307-017-1134-2] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 8.7] [Reference Citation Analysis]
5 Baart VM, van Manen L, Bhairosingh SS, Vuijk FA, Iamele L, de Jonge H, Scotti C, Resnati M, Cordfunke RA, Kuppen PJK, Mazar AP, Burggraaf J, Vahrmeijer AL, Sier CFM. Side-by-Side Comparison of uPAR-Targeting Optical Imaging Antibodies and Antibody Fragments for Fluorescence-Guided Surgery of Solid Tumors. Mol Imaging Biol 2021. [PMID: 34642899 DOI: 10.1007/s11307-021-01657-2] [Reference Citation Analysis]
6 Hübner R, Benkert V, Cheng X, Wängler B, Krämer R, Wängler C. Probing two PESIN-indocyanine-dye-conjugates: significance of the used fluorophore. J Mater Chem B 2020;8:1302-9. [PMID: 31967633 DOI: 10.1039/c9tb01794a] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
7 Alam IS, Steinberg I, Vermesh O, van den Berg NS, Rosenthal EL, van Dam GM, Ntziachristos V, Gambhir SS, Hernot S, Rogalla S. Emerging Intraoperative Imaging Modalities to Improve Surgical Precision. Mol Imaging Biol 2018;20:705-15. [DOI: 10.1007/s11307-018-1227-6] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 7.3] [Reference Citation Analysis]
8 Hübner R, Paretzki A, von Kiedrowski V, Maspero M, Cheng X, Davarci G, Braun D, Damerow H, Judmann B, Filippou V, Dallanoce C, Schirrmacher R, Wängler B, Wängler C. PESIN Conjugates for Multimodal Imaging: Can Multimerization Compensate Charge Influences on Cell Binding Properties? A Case Study. Pharmaceuticals (Basel) 2021;14:531. [PMID: 34199635 DOI: 10.3390/ph14060531] [Reference Citation Analysis]
9 Baart VM, Boonstra MC, Sier CFM. uPAR directed-imaging of head-and-neck cancer. Oncotarget 2017;8:20519-20. [PMID: 28423554 DOI: 10.18632/oncotarget.16240] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
10 Juhl K, Christensen A, Rubek N, Karnov KKS, von Buchwald C, Kjaer A. Improved surgical resection of metastatic pancreatic cancer using uPAR targeted in vivo fluorescent guidance: comparison with traditional white light surgery. Oncotarget 2019;10:6308-16. [PMID: 31695839 DOI: 10.18632/oncotarget.27220] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
11 Linders D, Deken M, van der Valk M, Tummers W, Bhairosingh S, Schaap D, van Lijnschoten G, Zonoobi E, Kuppen P, van de Velde C, Vahrmeijer A, Farina Sarasqueta A, Sier C, Hilling D. CEA, EpCAM, αvβ6 and uPAR Expression in Rectal Cancer Patients with a Pathological Complete Response after Neoadjuvant Therapy. Diagnostics (Basel) 2021;11:516. [PMID: 33799475 DOI: 10.3390/diagnostics11030516] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Hübner R, Cheng X, Wängler B, Wängler C. Functional Hybrid Molecules for the Visualization of Cancer: PESIN-Homodimers Combined with Multimodal Molecular Imaging Probes for Positron Emission Tomography and Optical Imaging: Suited for Tracking of GRPR-Positive Malignant Tissue*. Chemistry 2020;26:16349-56. [PMID: 32618007 DOI: 10.1002/chem.202002386] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
13 Mahalingam SM, Dudkin VY, Goldberg S, Klein D, Yi F, Singhal S, O’neil KT, Low PS. Evaluation of a Centyrin-Based Near-Infrared Probe for Fluorescence-Guided Surgery of Epidermal Growth Factor Receptor Positive Tumors. Bioconjugate Chem 2017;28:2865-73. [DOI: 10.1021/acs.bioconjchem.7b00566] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
14 Baart VM, Houvast RD, de Geus-Oei LF, Quax PHA, Kuppen PJK, Vahrmeijer AL, Sier CFM. Molecular imaging of the urokinase plasminogen activator receptor: opportunities beyond cancer. EJNMMI Res 2020;10:87. [PMID: 32725278 DOI: 10.1186/s13550-020-00673-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
15 Skjøth-Rasmussen J, Azam A, Larsen CC, Scheie D, Juhl K, Kjaer A. A new uPAR-targeting fluorescent probe for optical guided intracranial surgery in resection of a meningioma-a case report. Acta Neurochir (Wien) 2021. [PMID: 34748074 DOI: 10.1007/s00701-021-05051-3] [Reference Citation Analysis]
16 Stepan KO, Li MM, Kang SY, Puram SV. Molecular margins in head and neck cancer: Current techniques and future directions. Oral Oncol 2020;110:104893. [PMID: 32702629 DOI: 10.1016/j.oraloncology.2020.104893] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
17 Leth JM, Mertens HDT, Leth-Espensen KZ, Jørgensen TJD, Ploug M. Did evolution create a flexible ligand-binding cavity in the urokinase receptor through deletion of a plesiotypic disulfide bond? J Biol Chem 2019;294:7403-18. [PMID: 30894413 DOI: 10.1074/jbc.RA119.007847] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
18 Zuo J, Huo M, Wang L, Li J, Chen Y, Xiong P. Photonic hyperthermal and sonodynamic nanotherapy targeting oral squamous cell carcinoma. J Mater Chem B 2020. [PMID: 32926057 DOI: 10.1039/d0tb01089h] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
19 Kurbegovic S, Juhl K, Sørensen KK, Leth J, Willemoe GL, Christensen A, Adams Y, Jensen AR, von Buchwald C, Skjøth-Rasmussen J, Ploug M, Jensen KJ, Kjaer A. IRDye800CW labeled uPAR-targeting peptide for fluorescence-guided glioblastoma surgery: Preclinical studies in orthotopic xenografts. Theranostics 2021;11:7159-74. [PMID: 34158842 DOI: 10.7150/thno.49787] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Jiao J, Zhang J, Yang F, Song W, Han D, Wen W, Qin W. Quicker, deeper and stronger imaging: A review of tumor-targeted, near-infrared fluorescent dyes for fluorescence guided surgery in the preclinical and clinical stages. Eur J Pharm Biopharm 2020;152:123-43. [PMID: 32437752 DOI: 10.1016/j.ejpb.2020.05.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 4.5] [Reference Citation Analysis]
21 Debie P, Hernot S. Emerging Fluorescent Molecular Tracers to Guide Intra-Operative Surgical Decision-Making. Front Pharmacol 2019;10:510. [PMID: 31139085 DOI: 10.3389/fphar.2019.00510] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 11.7] [Reference Citation Analysis]
22 Simón M, Jørgensen JT, Juhl K, Kjaer A. The use of a uPAR-targeted probe for photothermal cancer therapy prolongs survival in a xenograft mouse model of glioblastoma. Oncotarget 2021;12:1366-76. [PMID: 34262647 DOI: 10.18632/oncotarget.28013] [Reference Citation Analysis]
23 Christensen A, Kiss K, Lelkaitis G, Juhl K, Persson M, Charabi BW, Mortensen J, Forman JL, Sørensen AL, Jensen DH, Kjaer A, von Buchwald C. Urokinase-type plasminogen activator receptor (uPAR), tissue factor (TF) and epidermal growth factor receptor (EGFR): tumor expression patterns and prognostic value in oral cancer. BMC Cancer 2017;17:572. [PMID: 28841839 DOI: 10.1186/s12885-017-3563-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
24 Li S, Yuan C, Chen J, Chen D, Chen Z, Chen W, Yan S, Hu P, Xue J, Li R, Zheng K, Huang M. Nanoparticle Binding to Urokinase Receptor on Cancer Cell Surface Triggers Nanoparticle Disintegration and Cargo Release. Theranostics 2019;9:884-99. [PMID: 30809315 DOI: 10.7150/thno.29445] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 4.3] [Reference Citation Analysis]
25 Wojtynek NE, Mohs AM. Image-guided tumor surgery: The emerging role of nanotechnology. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2020;12:e1624. [PMID: 32162485 DOI: 10.1002/wnan.1624] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
26 Huisman BW, Cankat M, Bosse T, Vahrmeijer AL, Rissmann R, Burggraaf J, Sier CFM, van Poelgeest MIE. Integrin αvβ6 as a Target for Tumor-Specific Imaging of Vulvar Squamous Cell Carcinoma and Adjacent Premalignant Lesions. Cancers (Basel) 2021;13:6006. [PMID: 34885116 DOI: 10.3390/cancers13236006] [Reference Citation Analysis]
27 Baart VM, van Duijn C, van Egmond SL, Dijckmeester WA, Jansen JC, Vahrmeijer AL, Sier CFM, Cohen D. EGFR and αvβ6 as Promising Targets for Molecular Imaging of Cutaneous and Mucosal Squamous Cell Carcinoma of the Head and Neck Region. Cancers (Basel) 2020;12:E1474. [PMID: 32516897 DOI: 10.3390/cancers12061474] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
28 Zhang C, Zhao Y, Zhao N, Tan D, Zhang H, Chen X, Zhang H, An J, Shi C, Li M. NIRF Optical/PET Dual-Modal Imaging of Hepatocellular Carcinoma Using Heptamethine Carbocyanine Dye. Contrast Media Mol Imaging 2018;2018:4979746. [PMID: 29706843 DOI: 10.1155/2018/4979746] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
29 Mortensen OE, Nerup N, Thorsteinsson M, Svendsen MBS, Shiwaku H, Achiam MP. Fluorescence guided intraluminal endoscopy in the gastrointestinal tract: A systematic review. World J Gastrointest Endosc 2020; 12(10): 388-400 [PMID: 33133375 DOI: 10.4253/wjge.v12.i10.388] [Reference Citation Analysis]
30 Jensen MM, Barber ZB, Khurana N, Isaacson KJ, Steinhauff D, Green B, Cappello J, Pulsipher A, Ghandehari H, Alt JA. A dual-functional Embolization-Visualization System for Fluorescence image-guided Tumor Resection. Theranostics 2020;10:4530-43. [PMID: 32292513 DOI: 10.7150/thno.39700] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
31 Kain JJ, Birkeland AC, Udayakumar N, Morlandt AB, Stevens TM, Carroll WR, Rosenthal EL, Warram JM. Surgical margins in oral cavity squamous cell carcinoma: Current practices and future directions. Laryngoscope 2020;130:128-38. [PMID: 31025711 DOI: 10.1002/lary.27943] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]
32 Maspero M, Cheng X, von Kiedrowski V, Dallanoce C, Wängler B, Hübner R, Wängler C. Synthesis, Characterization and In Vitro Evaluation of Hybrid Monomeric Peptides Suited for Multimodal Imaging by PET/OI: Extending the Concept of Charge-Cell Binding Correlation. Pharmaceuticals (Basel) 2021;14:989. [PMID: 34681213 DOI: 10.3390/ph14100989] [Reference Citation Analysis]
33 Pagoto A, Garello F, Marini GM, Tripepi M, Arena F, Bardini P, Stefania R, Lanzardo S, Valbusa G, Porpiglia F, Manfredi M, Aime S, Terreno E. Novel Gastrin-Releasing Peptide Receptor Targeted Near-Infrared Fluorescence Dye for Image-Guided Surgery of Prostate Cancer. Mol Imaging Biol 2020;22:85-93. [DOI: 10.1007/s11307-019-01354-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
34 Demétrio de Souza França P, Guru N, Roberts S, Kossatz S, Mason C, Abrahão M, Ghossein RA, Patel SG, Reiner T. Fluorescence-guided resection of tumors in mouse models of oral cancer. Sci Rep 2020;10:11175. [PMID: 32636416 DOI: 10.1038/s41598-020-67958-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
35 Leth JM, Ploug M. Targeting the Urokinase-Type Plasminogen Activator Receptor (uPAR) in Human Diseases With a View to Non-invasive Imaging and Therapeutic Intervention. Front Cell Dev Biol 2021;9:732015. [PMID: 34490277 DOI: 10.3389/fcell.2021.732015] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]